Inhibition of the transcriptional repressor complex Bcl-6/BCoR induces endothelial sprouting but does not promote tumor growth

The oncogenic potential of the transcriptional repressor Bcl-6 (B-cell lymphoma 6) was originally discovered in non-Hodgkin patients and the soluble Bcl-6 inhibitor 79-6 was developed to treat diffuse large B-cell lymphomas with aberrant Bcl-6 expression. Since we found Bcl-6 and its co-repressor BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchberger, Elisabeth, Payrhuber, Dietmar, Harchi, Miriam El, Zagrapan, Branislav, Scheuba, Katharina, Zommer, Anna, Bugyik, Edina, Dome, Balazs, Kral, Julia Barbara, Schrottmaier, Waltraud Cornelia, Schabbauer, Gernot, Petzelbauer, Peter, Gröger, Marion, Bilban, Martin, Brostjan, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352177/
https://www.ncbi.nlm.nih.gov/pubmed/27880939
http://dx.doi.org/10.18632/oncotarget.13477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352177/
https://www.ncbi.nlm.nih.gov/pubmed/27880939
http://dx.doi.org/10.18632/oncotarget.13477

Ejemplares similares